== Causes of death of subjects with low and normal albumin levels HCC, hepatocellular carcinoma No significant differences were observed between the two organizations for mortality from cerebrovascular disease, cardiac disease, pneumonia, liver disease, diabetes mellitus, suicide, tuberculosis, a freak accident, feebleness of age, and others. == Multivariate analysis == Relating to multivariate analysis, five (S)-(-)-5-Fluorowillardiine reasons – 50 years or older, low albumin level (<4.0 g/L), irregular AST level, history of smoking, and absence of alcohol consumption - were associated with death. history of smoking, and absence of alcohol consumption - were associated with death. The adjusted odds ratios for these five factors were 20.65, 10.79, 2.58, 2.24 and 2.08, respectively, and each was statistically significant. == Conclusions == We display the serum albumin level is an self-employed risk element for mortality from all causes in the occupants of X town and an important prognostic indication. Improvement of hypoalbuminaemia should be considered for improvement of prognosis. == Background == Hypoalbuminemia can be caused by numerous conditions, including nephrotic syndrome [1,2], heart failure [3], liver disease [4,5] and malnutrition [6]. Most instances of hypoalbuminemia among hospitalized individuals are caused by acute and chronic inflammatory reactions [7]. Moreover, a strong association has been reported between the serum albumin level and mortality [8]. The serum albumin level is an self-employed risk element for all-cause mortality in older individuals and an important prognostic indication [9]. From 1990, we have continued carrying out health screenings of the occupants of X town (adult populace: 7,389) in northern Kyushu, Japan, where the prevalence of hepatitis C computer virus (HCV) illness is the highest in the country and the mortality from liver cancer is about three times the national common [10-23]. The positive rates of antibodies to HCV (anti-HCV), HCV RNA and hepatitis B surface antigen (HBsAg) were, respectively, 23.6%, 17.9%, and 2.6% in 1990 [15]. We shown extrahepatic manifestations as well as the natural program and carcinogenesis of HCV-infected individuals in X town. There has been little conversation about hypoalbuminemia and mortality over the long term in occupants of the area. In this study, we identified whether serum albumin levels impact on the life prognosis of the occupants of X town after a follow-up period of 12 years. == Methods == == Subjects == In 1990, 10% (739 people) of the 7,389 inhabitants were selected randomly and, as a result, (S)-(-)-5-Fluorowillardiine 509 subjects participated (S)-(-)-5-Fluorowillardiine in the study for examination of liver diseases accompanying HCV or hepatitis B computer virus (HBV) infections [15]. We analyzed 509 consecutive occupants prospectively for 12 years. Of these 509 subjects, 69 had died and 55 experienced moved to additional regions by May 31, 2002. Consequently, 385 of the original inhabitants investigated in 1990 continued to reside in X town in May 2002. As a result, 454 occupants, whose existence (S)-(-)-5-Fluorowillardiine and death could be confirmed between 1990 and 2002, were analyzed. The albumin levels were classified into two organizations, low (<4.0 g/L, group A) and normal (4.0 g/L, group B) and there were 25 subject matter in group A and 429 in group B. == Serological assays == In 1990, sera were provided by the 454 subjects for the following serological assays: albumin, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Sera were also examined for the (S)-(-)-5-Fluorowillardiine presence or TGFB2 absence of markers of HCV and HBV illness. Anti-HCV was measured by a chemiluminescent enzyme immunoassay (CLEIA) kit (Lumipulse II HCV, Fujirebio Inc., Tokyo, Japan). HCV RNA was recognized in the sera using the Amplicor HCV test (Nippon Roche, Tokyo, Japan). HBsAg was assayed by a chemiluminescent immunoassay (CLIA) kit (Architect, HBsAg QT, Dainabot Co. Ltd., Tokyo, Japan). Ultrasonographic examination of subjects with abnormalities in their liver function checks and who have been positive for anti-HCV or HBsAg was performed in order to investigate.